MetLife: Buyers Defend the 20 EMAMET is seeing strong buying interest after retracing to the 20 EMA, a level that has repeatedly attracted buyers during the stock’s uptrend. The recent bounce reinforces the bullish setup, with the stock trading above both the 20 and 50 EMAs.
MetLife, Inc. is a $63bn market cap company that provide
Compare with MetLife, Inc.
Key facts today
MetLife via MetLife Investment Management closed Galaxy 38 CLO targeting $450M par; PineBridge is collateral manager and BofA Securities was arranger. MIM manages CLOs and had $748.1B AUM at 6/30/26 1
5.26 USD
3.38 B USD
77.08 B USD
531.43 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Michel A. Khalaf
Website
Headquarters
New York
Founded
1868
IPO date
Apr 5, 2000
ISIN
US59156R1086
CUSIP
59156R108
FIGI
BBG000BB6KF5
Identifiers
ISIN US59156R1086
MetLife, Inc. engages in providing insurance and financial services to individual and institutional customers. It operates through the following segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, MetLife Holdings, and Corporate and Other. The Group Benefits segment offers group life insurance products with renewable term policies. The RIS segment contains short and long-duration products, including capital market products, pension risk transfers, structured settlements, and other benefit funding products. The Asia segment focuses on Japan only and offers traditional life insurance, and accident and health products. The MetLife Holdings segment includes traditional and universal life products. The Corporate and Other segment refers to surplus investment portfolios used to fund capital and liquidity needs. The company was founded on March 24, 1868 and is headquartered in New York, NY.
MetLife Testing Major ResistanceMetLife has rallied strongly into the $88–89 resistance zone, an area that has rejected price multiple times in the past. The stock is now at a key breakout level where the next move could set the direction for the coming months.
Short-Term Outlook
A daily close above $89 would confirm a bullish
MetLife at a Critical TrendlineOn the daily chart, the stock has been following a long-term upward trendline since 2020. The price is currently testing this major support level, making it a key decision zone.
If the trendline holds, the stock could continue its upward trajectory. A breakdown may trigger a deeper correction.
Sh
MetLife at a Major Turning Point: Trendline Bounce or Breakdown?The chart shows MET sitting directly on a major long-term ascending trendline that has been respected multiple times since 2020. This level is a critical decision zone for the next major move.
Bullish Scenario (Primary)
If the price holds above the trendline and shows upward momentum:
• Target 1
MET - Potential swing downs =======
Volume
=======
- Neutral
==========
Price Action
==========
- Double Top
=================
Technical Indicators
=================
- Ichimoku
>>> price within cloud
>>> Green kumo contracting
>>> Tenken + Chiku - approaching clouds and sloping down
>>> Kijun - approaching clouds and
MET | Life Insurance Industry Will Rise | LONGMetLife, Inc. engages in providing insurance and financial services to individual and institutional customers. It operates through the following segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, MetLife Holdings, and Corporate and Other. The Group Benefits segment offers group l
$MET u again - Bullish StanceNYSE:MET 's chart reveals classic rally-base-rally structure: strong uptrend channel (green), consolidation phase at $80-85, sharp April selloff to $68 creating new base, now rallying from this foundation.
Current price ($79.79) testing previous support-turned-resistance. Watch for breakout above
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateJul 15, 2052
Coupon5.00% (Fixed)
Maturity dateJan 15, 2054
Coupon5.25% (Fixed)
Maturity dateMar 1, 2045
Coupon4.05% (Fixed)
Maturity dateMay 13, 2046
Coupon4.60% (Fixed)
Maturity dateNov 13, 2043
Coupon4.88% (Fixed)
Maturity dateAug 13, 2042
Coupon4.13% (Fixed)
Maturity dateDec 15, 2044
Coupon4.72% (Fixed)
Maturity dateFeb 6, 2041
Coupon5.88% (Fixed)
Maturity dateJun 15, 2035
Coupon5.70% (Fixed)
Maturity dateDec 15, 2034
Coupon5.30% (Fixed)
Maturity dateJun 15, 2034
Coupon6.38% (Fixed)
See all MET bonds
Frequently asked questions
The current price of MET is 97.23 USD — it has increased by 0.48% in the past 24 hours. Watch MetLife, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange MetLife, Inc. stocks are traded under the ticker MET.
MET stock has risen by 1.72% compared to the previous week, the month change is a 0.49% rise, over the last year MetLife, Inc. has showed a 20.05% increase.
We've gathered analysts' opinions on MetLife, Inc. future price: according to them, MET price has a max estimate of 119.00 USD and a min estimate of 87.00 USD. Watch MET chart and read a more detailed MetLife, Inc. stock forecast: see what analysts think of MetLife, Inc. and suggest that you do with its stocks.
MET stock is 3.06% volatile and has beta coefficient of 0.71. Track MetLife, Inc. stock price on the chart and check out the list of the most volatile stocks — is MetLife, Inc. there?
Today MetLife, Inc. has the market capitalization of 62.42 B, it has decreased by −2.18% over the last week.
Yes, you can track MetLife, Inc. financials in yearly and quarterly reports right on TradingView.
MetLife, Inc. is going to release the next earnings report on Nov 4, 2026. Keep track of upcoming events with our Earnings Calendar.
MET earnings for the last quarter are 2.43 USD per share, whereas the estimation was 2.30 USD resulting in a 5.87% surprise. The estimated earnings for the next quarter are 2.56 USD per share. See more details about MetLife, Inc. earnings.
MetLife, Inc. revenue for the last quarter amounts to 19.07 B USD, despite the estimated figure of 19.67 B USD. In the next quarter, revenue is expected to reach 20.10 B USD.
MET net income for the last quarter is 736.00 M USD, while the quarter before that showed 1.19 B USD of net income which accounts for 0.00% change. Track more MetLife, Inc. financial stats to get the full picture.
Yes, MET dividends are paid quarterly. The last dividend per share was 0.59 USD. As of today, Dividend Yield (TTM)% is 2.36%. Tracking MetLife, Inc. dividends might help you take more informed decisions.
MetLife, Inc. dividend yield was 2.85% in 2025, and payout ratio reached 47.69%. The year before the numbers were 2.63% and 36.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 17, 2026, the company has 46 K employees. See our rating of the largest employees — is MetLife, Inc. on this list?
Like other stocks, MET shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MetLife, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MetLife, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MetLife, Inc. stock shows the buy signal. See more of MetLife, Inc. technicals for a more comprehensive analysis.









